Association of C-reactive protein (CRP) with efficacy of avelumab + axitinib (A + Ax) in advanced renal cell carcinoma (aRCC): Long-term follow-up results from JAVELIN Renal 101.

Authors

null

Yoshihiko Tomita

Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan

Yoshihiko Tomita , James Larkin , Balaji Venugopal , John B. A. G. Haanen , Hiro-Omi Kanayama , Masatoshi Eto , Marc-Oliver Grimm , Yosuke Fujii , Yoshiko Umeyama , Mariangela Mariani , Alessandra Di Pietro , Toni K. Choueiri

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Clinical Trial Registration Number

NCT02684006

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 4548)

DOI

10.1200/JCO.2021.39.15_suppl.4548

Abstract #

4548

Poster Bd #

Online Only

Abstract Disclosures